Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Body dysmorphic-induced Androgenic Anabolic Steroids usage and its association with mental health outcomes

View ORCID ProfileAhmed Gawash, View ORCID ProfileHasan Zia, View ORCID ProfileDavid F. Lo
doi: https://doi.org/10.1101/2023.01.14.23284562
Ahmed Gawash
1Department of Medicine, Rowan University School of Osteopathic Medicine, Stratford, NJ
2American Preventive Screening & Education Association (APSEA), Stratford, NJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ahmed Gawash
  • For correspondence: ahmedgawash2000{at}gmail.com
Hasan Zia
2American Preventive Screening & Education Association (APSEA), Stratford, NJ
3Department of Biology, Rutgers, the State University of New Jersey, New Brunswick, NJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hasan Zia
David F. Lo
1Department of Medicine, Rowan University School of Osteopathic Medicine, Stratford, NJ
2American Preventive Screening & Education Association (APSEA), Stratford, NJ
3Department of Biology, Rutgers, the State University of New Jersey, New Brunswick, NJ
4Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
MBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David F. Lo
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

This systematic review aims to examine the relationship between body dysmorphic disorder (BDD), anabolic-androgenic steroid (AAS) use, and mental health outcomes. Previous research has suggested that individuals with BDD may be more likely to abuse AAS due to their preoccupation with appearance, but AAS use may worsen mental health issues in this population.

The review will also consider potential interventions and treatments that may help mitigate the detrimental effects of AAS use in individuals with BDD. The review will include only published literature and will utilize electronic databases from a variety of databases such as PubMed, Scopus, Embase, and PsycINFO. Two reviewers independently screened studies for inclusion, extract data, and assessed the quality of the evidence. The findings of this review will provide important insights into the complex relationship between BDD, AAS use, and mental health outcomes, and will inform the development of effective interventions and treatments for individuals with BDD who may be considering AAS use.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Email addresses Ahmed Gawash Gawash14{at}rowan.edu

    Hasan Zia hz423{at}scarletmail.rutgers.edu

    David F. Lo Lodavi26{at}rowan.edu

  • Funding: No funding was received for this study/paper.

  • Competing interests: The authors declare that they have no competing interests.

Data Availability

All data produced in the present work are contained in the manuscript

  • Abbreviations

  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted January 17, 2023.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Body dysmorphic-induced Androgenic Anabolic Steroids usage and its association with mental health outcomes
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Body dysmorphic-induced Androgenic Anabolic Steroids usage and its association with mental health outcomes
    Ahmed Gawash, Hasan Zia, David F. Lo
    medRxiv 2023.01.14.23284562; doi: https://doi.org/10.1101/2023.01.14.23284562
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Body dysmorphic-induced Androgenic Anabolic Steroids usage and its association with mental health outcomes
    Ahmed Gawash, Hasan Zia, David F. Lo
    medRxiv 2023.01.14.23284562; doi: https://doi.org/10.1101/2023.01.14.23284562

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Psychiatry and Clinical Psychology
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)